ED
CTIC

Exane Derivatives’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Exane Derivatives’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Hold
0
– – – 703
2016
Q3 		– Hold
0
– – – 672
2016
Q2 		– Hold
0
– – – 660
2016
Q1 		– Hold
0
– – – 587
2015
Q4 		– Hold
0
– – – 499
2015
Q3 		– Sell
-30
Closed -$518 – 530
2015
Q2 		$596 Hold
30
– – ﹤0.01% 455
2015
Q1 		$567 Hold
30
– – ﹤0.01% 458
2014
Q4 		$700 Buy
+30
New +$694 ﹤0.01% 482

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.2B AUM 16.34% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return